Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA overseas offices open by year-end

This article was originally published in The Tan Sheet

Executive Summary

Health and Human Services Secretary Mike Leavitt lays out a timeline Oct. 16 for opening and staffing foreign FDA offices to work with local authorities and industries that export to the U.S. China will be first, with FDA staffers slated to begin in Beijing by the end of 2008 and other offices opening in Shanghai and Guangzhou next year. FDA also will open an office in New Delhi, India, in 2008. "Opening these offices will mark a key milestone in the globalization of our efforts to enhance the safety of imported food and medical products," Leavitt says. Working closely with foreign regulators is a large component of FDA's Import Safety Action Plan, but dietary supplement industry stakeholders have warned that overseas offices will siphon resources from other agency programs (1"The Tan Sheet" Oct. 13, 2008, p. 12 and 2"The Tan Sheet" Feb. 11, 2008, p. 3)

Related Content

Topics

UsernamePublicRestriction

Register

PS102211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel